Related Publications

Figueroa et al., medRxiv 2021. 04.13.21255409; doi: https://doi.org/10.1101/2021.04.13.21255409

Efficacy of a nasal spray containing Iota-Carrageenan in the prophylaxis of COVID19 in hospital personnel dedicated to patients care with COVID-19 disease

Related Publications

Hoseini-Tavassol et al., Infectious Disorders - Drug Targets, 2021, 20, 1-7

Natural Derived Nasal Spray; A Proposed Approach for COVID-19 Disease Control

Related Publications

Bichiri et al., Med Pharm Rep. 2021 Jan; 94(1): 28–34.

Safety and efficacy of iota-carrageenan nasal spray in treatment and prevention of the common cold

Related Publications

Schütz et al., American Journal of Physiology-Lung Cellular and Molecular Physiology, 2021, https://doi.org/10.1152/ajplung.00552.2020

Carrageenan containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures

Related Publications

Kramer et al., GMS Hygiene and Infection Control 2021, Vol. 16, ISSN 2196-5226

Virucidal gargling and virucidal nasal spray

Related Publications

Hirsch et al., Journal of Infectious Diseases & Travel Medicine 2020, 4 (S1): 000S1-007

Covid 19 and Ivermectin Prevention and Treatment Update

Related Publications

Carvallo et al., Journal of Biomedical Research and Clinical Investigation 2020; Volume 2 Isue 1.1007

Study of the Efficacy and Safety of Topical Ivermectin + Iota-Carrageenan in the Prophylaxis against COVID-19 in Health Personnel

Related Publications

Hemilä et al., Research Square 2020; 10.21203/rs.3.rs-108775/v1

Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: re-analysis of randomized trial data

Related Publications

Clausen et al., Cell 2020, 2020.09.033

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2

Related Publications

Lee, Marine Drugs 2020, 18, 435

Carrageenans as Broad-Spectrum Microbicides: Current Status and Challenges

Related Publications

Bansal et al., bioRxiv. 2020; 10.1101/2020.08.19.225854

Iota-carrageenan and Xylitol inhibit SARS-CoV-2 in cell culture

Related Publications

Chen et al., International Journal of Biological Macromolecules, 2020, 164, 331-343

Application prospect of polysaccharides in the development of anti-novelcoronavirus drugs and vaccines

Related Publications

Pereira, L., Critchley, A.T., Journal of Applied Phycology 2020

The COVID 19 novel coronavirus pandemic 2020: seaweeds to the rescue? Why does substantial, supporting research about the antiviral properties of seaweed polysaccharides seem to go unrecognized by the pharmaceutical community in these desperate times?

Related Publications

Eccles, The Open Virology Journal 2020, 14:9

Iota-Carrageenan as an Antiviral Treatment for the Common Cold

Related Publications

Eccles et al., Respiratory Research 2015, 16:121

Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial

Scientific Posters

Ludwig et al. 2013

Carrageenan nasal spray against common cold: a pooled analysis of two randomized, double-blind, placebo controlled studies

Scientific Posters

Morokutti-Kurz et al. 2013

Combinational antiviral therapy with Carragelose® and Zanamivir is synergistically active against influenza A virus infection

Scientific Posters

Nakowitsch et al. 2013

Combination of a corticosteroid and an anti-viral intranasal therapy

Scientific Posters

Nakowitsch et al. 2012

Antiviral Polymers - A Novel Concept for Prophylactic and Therapeutic Interventions

Scientific Posters

Reutterer et al. 2011

Combination of carrageenan and a neuraminidase inhibitor as superior treatment for influenza A

Scientific Posters

Eccles et al. 2010

Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled Pilot study in volunteers with early symptoms of the common cold

Scientific Posters

Grassauer et al. 2009

Iota-Carrageenan is a potent Inhibitor of rhinovirus infection

Corporate Design Assets

Carragelose®

Original version - Registered Trade Mark - Portable Network Graphics

Corporate Design Assets

Carragelose™

Original version - Unregistered Trade Mark - Portable Network Graphics

Corporate Design Assets

Carragelose™

Black version - Unregistered Trade Mark - Portable Network Graphics

Corporate Design Assets

Corpoarte Design Booklet

Basic information of the Carragelose® logo and the use on artworks.

Corporate Design Assets

Carragelose®

Black version - Registered Trade Mark - Portable Network Graphics